"Platelet-Rich Plasma Epidural Injection an Emerging Strategy in Lumbar Disc Herniation"

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

May 1, 2021

Study Completion Date

June 30, 2021

Conditions
PRP
Interventions
DRUG

platelet rich plasma

1\. 26 ml of blood was obtained from each patient (6ml each in 4 CPDA and 2ml in EDTA for CBC) 2. First-spin of 900g for 5 minutes (Kokusan, H-19alpha, 25°C) 3. Three layers formed: transfer top layer (platelet poor plasma) and middle layer (platelets and WBC) to another sterile tube (about 3.3 ml), discard bottom layer (RBC) 4. Second-spin of 1000g for 10 minutes 5. The upper one third was discarded (platelet poor plasma) by pipet, the remaining was mixed by turning 10 times 6. Total 4 ml of PRP

DRUG

Triamcinolone

40 mg triamcinolone with 1% lidocaine, total of 2 ml

Trial Locations (1)

20110

Chuenrutai, Chon Buri

All Listed Sponsors
lead

Queen Savang Vadhana Memorial Hospital, Thailand

OTHER

NCT05234840 - "Platelet-Rich Plasma Epidural Injection an Emerging Strategy in Lumbar Disc Herniation" | Biotech Hunter | Biotech Hunter